These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38041205)
1. An Updated Comprehensive Pharmacovigilance Study of Drug-Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data. Kunyu L; Shuping S; Chang S; Yiyue C; Qinyu X; Ting Z; Bin W J Clin Pharmacol; 2024 Apr; 64(4):478-489. PubMed ID: 38041205 [TBL] [Abstract][Full Text] [Related]
2. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database. Welch HK; Kellum JA; Kane-Gill SL Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524 [TBL] [Abstract][Full Text] [Related]
3. Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database. Yang Q; Wang J; Wang M; Zhang S; He QQ BMC Pharmacol Toxicol; 2024 Sep; 25(1):64. PubMed ID: 39267168 [TBL] [Abstract][Full Text] [Related]
4. Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study. Huang J; Cai J; Ye Q; Jiang Q; Lin H; Wu L BMJ Open; 2023 Aug; 13(8):e071456. PubMed ID: 37536976 [TBL] [Abstract][Full Text] [Related]
5. DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020. Jedlowski PM; Jedlowski MF; Fazel MT Am J Clin Dermatol; 2021 Nov; 22(6):891-900. PubMed ID: 34287770 [TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase tyrosine kinase inhibitors associated gastrointestinal obstruction, perforation, and ulceration: an analysis of the FDA adverse event reporting system database (FAERS). Huang J; Zhao Y; Cao Y; Zhang Q; Ran D; Li J; Luo L; Qiu F; Meng L Int J Clin Pharm; 2022 Aug; 44(4):993-1003. PubMed ID: 35776375 [TBL] [Abstract][Full Text] [Related]
7. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data. Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268 [TBL] [Abstract][Full Text] [Related]
8. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698 [TBL] [Abstract][Full Text] [Related]
9. A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab. Chen Z; Li M; Li S; Li Y; Wu J; Qiu K; Yu X; Huang L; Chen G Expert Opin Drug Saf; 2023 Apr; 22(4):339-342. PubMed ID: 36178002 [TBL] [Abstract][Full Text] [Related]
10. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review. Moore DC; Elmes JB; Arnall JR; Strassel SA; Patel JN Int Immunopharmacol; 2024 Mar; 129():111606. PubMed ID: 38359661 [TBL] [Abstract][Full Text] [Related]
11. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data. Wei C; Liu Y; Jiang A; Wu B Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753 [TBL] [Abstract][Full Text] [Related]
12. Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database. Zhang S; Wang Y; Qi Z; Tong S; Zhu D Int J Clin Pharm; 2024 Apr; 46(2):471-479. PubMed ID: 38245664 [TBL] [Abstract][Full Text] [Related]
13. Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis. Jiang A; Wei C; Zhu W; Wu F; Wu B Ther Adv Drug Saf; 2024; 15():20420986241244585. PubMed ID: 38715707 [TBL] [Abstract][Full Text] [Related]
14. Does eltrombopag lead to thrombotic events? A pharmacovigilance study of the FDA adverse event reporting system. Jiang JJ; Zhao B; Li J J Clin Pharm Ther; 2022 Oct; 47(10):1556-1562. PubMed ID: 35644838 [TBL] [Abstract][Full Text] [Related]
15. Spectrum of psychiatric adverse reactions to cyclin-dependent kinases 4/6 inhibitors: A pharmacovigilance analysis of the FDA adverse event reporting system. Xiao Z; Cao J; Wu S; Zhou T; Li C; Duan J; Yang Z; Xu F CNS Neurosci Ther; 2024 Jul; 30(7):e14862. PubMed ID: 39009505 [TBL] [Abstract][Full Text] [Related]
16. Post-marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System. Zhuang W; Xu J; Wu Y; Yang J; Lin X; Liao Y; Wan J; Weng L; Lin W Br J Clin Pharmacol; 2023 Sep; 89(9):2830-2842. PubMed ID: 37170890 [TBL] [Abstract][Full Text] [Related]
17. Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system. Kumar V; Singh AP; Wheeler N; Galindo CL; Kim JJ Expert Opin Drug Saf; 2021 Nov; 20(11):1443-1450. PubMed ID: 34259127 [TBL] [Abstract][Full Text] [Related]
18. Safety of cardiovascular disease drugs approved between 2014 and 2021 in the US: a pharmacovigilance analysis. Park T; Hwang M Expert Rev Cardiovasc Ther; 2024 Jun; 22(6):273-283. PubMed ID: 38722712 [TBL] [Abstract][Full Text] [Related]
19. Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database. Wei L; Tian Y; Chen X; Guo X; Chen C; Zheng Y; Xu J; Ye X Int J Clin Pharm; 2023 Jun; 45(3):622-629. PubMed ID: 36848023 [TBL] [Abstract][Full Text] [Related]
20. Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022. Huang H; Li L; Wu M; Liu Z; Zhao Y; Peng J; Ren X; Chen S BMC Pharmacol Toxicol; 2023 Dec; 24(1):73. PubMed ID: 38049920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]